In ESCC, mass spectrometry studies identified CNPY2 as an interacting partner of Ezrin, a protein that links the plasma membrane to the cytoskeleton and plays a key role in ESCC progression. The gene discussed is CNPY2; the disease is esophageal squamous cell carcinoma.